Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Acta otorrinolaringol. esp ; 68(6): 336-343, nov.-dic. 2017. tab, graf
Article in Spanish | IBECS | ID: ibc-169017

ABSTRACT

Introducción y objetivos: El síndrome de apnea-hipopnea del sueño (SAHS) pediátrico engloba alteraciones multisistémicas que afectan al estado general de salud, valorado indirectamente mediante el estudio de la demanda asistencial. Objetivo: cuantificar la frecuentación de consultas médicas en niños con SAHS durante 5 años y compararla con una población sana. Métodos: Estudio casos-control longitudinal ambispectivo en un hospital del sistema nacional de salud. Reclutamos a 69 niños remitidos por SAHS sin otras patologías para que la demanda asistencial fuera predominantemente atribuida al SAHS. Se seleccionó a otros 69 niños sanos como grupo control. Obtuvimos datos de frecuentación durante 5 años: el año en el que se realizó el tratamiento del SAHS («año 0»), 1 y 2 años antes («año -1» y «año -2»), y 1 y 2 años tras el tratamiento («año+1» y «año+2»). Resultados: El índice de frecuentación (IF), descrito como cociente entre demanda asistencial por los niños con SAHS y niños sanos, fue 1,89 durante el año -2 y 2,15 durante el año -1 (p < 0,05). El tratamiento disminuyó la utilización, con IF de 1,59 durante el año+1 y 1,72 en el año + 2 (p < 0,05). Las principales causas de sobrefrecuentación fueron otorrinolaringológicas y neumológicas. Conclusiones: Los niños con SAHS muestran mayor demanda asistencial, al menos 2 años antes del tratamiento, lo que implica un deterioro de la salud global que pudiera estar presente años antes de que la abordemos. El tratamiento repercute en una mejora, aunque permanece alta tras el tratamiento, sugiriendo enfermedad residual o secuelas (AU)


Introduction and objectives: Paediatric Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAS) is a multisystemic condition affecting child's health status that may be investigated analyzing demand for healthcare. Objective: to quantify the frequency of medical consultations in children with OSAS over a 5-year period, compared to a healthy population. Methods: A longitudinal, case-control, ambispective study was conducted at a hospital pertaining to the national public health system. 69 consecutive children referred for OSAS were recruited with no diseases other than OSAS so that healthcare demand was purely attributed to this condition. Matched healthy control children were selected to compare these data. Data regarding frequency of the medical consultations were obtained over 5 years: the year of the treatment ("Year 0"), 1 and 2 years before ("Year -1" and "Year -2" respectively), and 1 and 2 years after treatment ("Year+1" and "Year+2"). Results: Frequentation Index (FI), as ratio between the use of health services by OSAS children and healthy controls was 1.89 during Year-2, and 2.15 during Year-1 (P < .05). Treatment diminishes utilization, with FI of 159 during year+1 and 1.72 during year + 2 (P < .05). The main causes of attendance were otolaryngological and pneumological diseases, improving after treatment. Conclusions: Children suffering from OSAS demand more healthcare services, at least 2 years before treatment, implying that the disease could be present years before we manage it. Therapeutic actions improve healthcare services utilization, although remain higher than for controls, which suggests OSAS sequelae or residual disease (AU)


Subject(s)
Humans , Child , Sleep Apnea, Obstructive/epidemiology , Sleep Apnea, Central/epidemiology , Polysomnography , Health Services Needs and Demand/statistics & numerical data , Case-Control Studies
2.
Article in English, Spanish | MEDLINE | ID: mdl-28504184

ABSTRACT

INTRODUCTION AND OBJECTIVES: Paediatric Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAS) is a multisystemic condition affecting child's health status that may be investigated analyzing demand for healthcare. OBJECTIVE: to quantify the frequency of medical consultations in children with OSAS over a 5-year period, compared to a healthy population. METHODS: A longitudinal, case-control, ambispective study was conducted at a hospital pertaining to the national public health system. 69 consecutive children referred for OSAS were recruited with no diseases other than OSAS so that healthcare demand was purely attributed to this condition. Matched healthy control children were selected to compare these data. Data regarding frequency of the medical consultations were obtained over 5 years: the year of the treatment ("Year0"), 1 and 2 years before ("Year -1" and "Year -2" respectively), and 1 and 2 years after treatment ("Year+1" and "Year+2") RESULTS: Frequentation Index (FI), as ratio between the use of health services by OSAS children and healthy controls was 1.89 during Year-2, and 2.15 during Year-1 (P<.05). Treatment diminishes utilization, with FI of 159 during year+1 and 1.72 during year+2 (P<.05). The main causes of attendance were otolaryngological and pneumological diseases, improving after treatment. CONCLUSIONS: Children suffering from OSAS demand more healthcare services, at least 2 years before treatment, implying that the disease could be present years before we manage it. Therapeutic actions improve healthcare services utilization, although remain higher than for controls, which suggests OSAS sequelae or residual disease.


Subject(s)
Health Resources/statistics & numerical data , Health Services Needs and Demand , Health Services/statistics & numerical data , Sleep Apnea, Obstructive/therapy , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Male , Polysomnography , Prospective Studies , Referral and Consultation/statistics & numerical data , Retrospective Studies , Sleep Apnea, Obstructive/epidemiology , Snoring/epidemiology , Snoring/etiology , Spain/epidemiology , Symptom Assessment
3.
Acta otorrinolaringol. esp ; 68(2): 98-105, mar.-abr. 2017. tab, ilus
Article in Spanish | IBECS | ID: ibc-161069

ABSTRACT

Introducción. Las crisis de hipo suelen ser autolimitadas y benignas, pero los episodios prolongados alteran la calidad de vida y requieren asistencia, ya que existen causas identificables que el otorrinolaringólogo debe conocer para su diagnóstico y tratamiento. Su manifestación última es un ruido glótico espasmódico con alteraciones cervicales características. Pacientes y métodos. Desde 1979 se revisaron todos los casos que consultaron por hipo persistente o recidivante, anotando cronobiología, patología concomitante, resultados de las exploraciones, tratamiento y respuestas al mismo. Resultados. Se asistieron 37 pacientes con una edad media de 45,5±13,5 años, de los cuales 30 eran varones; 23 pacientes (el 62%) presentaron hipo persistente. En 24 casos (el 65%) se evidenció una causa potencialmente asociable: enfermedades del esófago en 14 —la mayoría reflujo gastroesofágico— y en 8 se apreció o descubrió patología oncológica concomitante. Solo 3 casos fueron intervenidos como resultado de los hallazgos efectuados. Los protocolos de tratamiento incluyeron metoclopramida en 18 sujetos, clorpromazina en 17 y baclofeno en 13, pero también carbamazepina o haloperidol. Se empleó neuroestimulación del nervio frénico en 6 pacientes. El hipo desapareció en 32 casos. De los 22 sujetos en los que se pudo efectuar seguimiento, se constató recidiva en 5 —precisando por ello nuevas terapias— y 11 fallecieron. Conclusiones. El hipo crónico implica un reto multidisciplinar con potencial afectación en cabeza y cuello, una sistemática diagnóstica de descarte, frecuente patología de base esofágica y una incidencia de neoplasia maligna alta. Los agentes procinéticos y neurolépticos con efecto antidopaminérgico y anticolinérgico suponen la base del tratamiento (AU)


Introduction. Hiccup crises are generally benign and self-limiting, but longer episodes affect quality of life and must be treated. There are recognisable causes that otorhinolaryngologists must know and be aware for diagnosis and therapeutic alternatives. The main expression is a spasmodic glottic noise with characteristic neck alterations. Patients and methods. This was a retrospective study from 1979 with patients suffering persistent or recurrent hiccups. Chronobiology, comorbidity, findings from explorations, therapies and outcomes were noted. Thirty-seven patients were studied (mean age, 45.5±13.5 years; 30 males), with persistent hiccups in 23 (62%). Results. A potential associated aetiology was observed in 24 cases (65%): oesophageal disorders —mainly gastroesophageal reflux— were detected in 14 cases and concomitant oncological disease was found in 8. Only 3 cases were admitted for surgery due to these findings. Therapeutic strategies with metoclopramide were used in 18 subjects, chlorpromazine in 17 and baclofen in 13, while carbamazepine or haloperidol were used in a minority. Phrenic nerve stimulation was employed in 6 patients. Hiccups disappeared in 32 cases. Out of 22 cases for which follow-up was possible, the hiccups recurred in 5 subjects (the subjects requiring new therapies) and 11 patients died. Conclusions. Chronic hiccup represents a multidisciplinary challenge that includes potential head and neck affection, a diagnostic schedule for ruling out causes, frequent base oesophageal alterations and high incidence of malignant neoplasm. Prokinetic and neuroleptic agents with antidopaminergic and anticholinergic effects are the pillars of its treatment (AU)


Subject(s)
Humans , Male , Female , Adult , Hiccup/diagnosis , Hiccup/therapy , Quality of Life , Metoclopramide/therapeutic use , Chlorpromazine/therapeutic use , Baclofen/therapeutic use , Carbamazepine/therapeutic use , Haloperidol/therapeutic use , Cholinergic Antagonists/therapeutic use , Hiccup/etiology , Antipsychotic Agents/therapeutic use , Retrospective Studies , Comorbidity , Aerophagy/complications , Stress, Psychological/complications
4.
Acta Otorrinolaringol Esp ; 68(2): 98-105, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-27542994

ABSTRACT

INTRODUCTION: Hiccup crises are generally benign and self-limiting, but longer episodes affect quality of life and must be treated. There are recognisable causes that otorhinolaryngologists must know and be aware for diagnosis and therapeutic alternatives. The main expression is a spasmodic glottic noise with characteristic neck alterations. PATIENTS AND METHODS: This was a retrospective study from 1979 with patients suffering persistent or recurrent hiccups. Chronobiology, comorbidity, findings from explorations, therapies and outcomes were noted. Thirty-seven patients were studied (mean age, 45.5±13.5 years; 30 males), with persistent hiccups in 23 (62%). RESULTS: A potential associated aetiology was observed in 24 cases (65%): oesophageal disorders -mainly gastroesophageal reflux- were detected in 14 cases and concomitant oncological disease was found in 8. Only 3 cases were admitted for surgery due to these findings. Therapeutic strategies with metoclopramide were used in 18 subjects, chlorpromazine in 17 and baclofen in 13, while carbamazepine or haloperidol were used in a minority. Phrenic nerve stimulation was employed in 6 patients. Hiccups disappeared in 32 cases. Out of 22 cases for which follow-up was possible, the hiccups recurred in 5 subjects (the subjects requiring new therapies) and 11 patients died. CONCLUSIONS: Chronic hiccup represents a multidisciplinary challenge that includes potential head and neck affection, a diagnostic schedule for ruling out causes, frequent base oesophageal alterations and high incidence of malignant neoplasm. Prokinetic and neuroleptic agents with antidopaminergic and anticholinergic effects are the pillars of its treatment.


Subject(s)
Hiccup , Otolaryngology , Adult , Aged , Chlorpromazine/therapeutic use , Chronic Disease , Combined Modality Therapy , Disease Management , Electric Stimulation Therapy , Esophageal Diseases/complications , Female , Gastroesophageal Reflux/complications , Hiccup/diagnosis , Hiccup/epidemiology , Hiccup/etiology , Hiccup/therapy , Humans , Male , Metoclopramide/therapeutic use , Middle Aged , Neoplasms/complications , Neoplasms/therapy , Otolaryngology/methods , Phrenic Nerve , Recurrence , Retrospective Studies , Young Adult
5.
Acta otorrinolaringol. esp ; 67(1): 23-32, ene.-feb. 2016. ilus, tab
Article in Spanish | IBECS | ID: ibc-148955

ABSTRACT

Objetivo: Valoración de factores relativos a la anatomía faríngea y a la técnica quirúrgica como posible causa de dolor postamigdalectomía. Material y métodos: Estudio longitudinal prospectivo sobre 42 pacientes amigdalectomizados mediante disección con bisturí frío y monopolar, cuantificando los tiempos quirúrgicos y de empleo de electrobisturí, tamaño amigdalar, el dolor postoperatorio mediante escala analógica visual (EAV) y test de 40 ítems (QoR-40) y sus secuelas en la tolerancia oral, pérdida de peso y la estancia hospitalaria. Las correlaciones entre variables cuantitativas se establecieron mediante coeficientes de regresión lineal. Resultados: La amigdalectomía duró 22,66 ± 7,07 minutos, retirando amígdalas con un volumen medio de 6.046,07 ± 3.866,20 mm3 y empleando electrocauterio 66,14 ± 37,77 segundos para aplicar 1.984,24± 1.133,32 julios por paciente. El Mallampatti más frecuente se estadió en los estadios 2 y 3, y el tamaño amigdalar fue mayoritariamente entre 2-3. La EAV se elevó y el índice QoR-40 descendió a las 24 horas y a los 7 días de forma estadísticamente no significativa. La cantidad de julios administrados fue la variable que mejor se correlacionó con el malestar medido en las escalas, los requerimientos de analgesia y corticoides, la pérdida de peso y la estancia hospitalaria. El dolor fue más acusado entre sujetos en los que existió manipulación quirúrgica de tejido periamigdalino. Conclusiones: La mejoría en el empleo de las técnicas de electrodisección con aplicaciones más limitadas y focalizadas de energía y la preservación de la mucosa periamigdalar son factores que podrían aliviar el nivel de dolor postamigdalectomía (AU)


Objective: Assessment of factors related to pharyngeal anatomy and surgical technique as possible causes of post-tonsillectomy pain. Materials and methods: This was a prospective observational study that included 42 patients undergoing tonsillectomy with cold and monopolar electric device dissection. We recorded duration of the entire operation, duration of electrocautery use, tonsil size and postoperative pain and discomfort assessed using a visual analogue scale (VS) and a 40-item questionnaire (QoR-40, Quality of Recovery), along with sequelae on returning to normal diet, weight loss and hospital stay. Correlations among quantitative variables were obtained by mean of lineal regression coefficients. Results: Duration of surgery was 22.66 ± 7.07 minutes, removing tonsils with a volume of 6046.07 ± 3866.20 mm3 and an electrocautery use time of 66.14 ± 37.77 seconds, applying 1984.24 ± 1133.32 joules per patient. The most frequently observed Mallampati classification and tonsil size scores were stages II and III. The VS score increased and QoR-40 decreased at 24 hours and 7 days, but differences were statistically non-significant. Joule amount used for electrocautery was the parameter that correlated the best with discomfort status as measured via assessment scores, analgesic and corticosteroid requirements, weight loss and hospital stay. Pain was higher in subjects submitted to peritonsillar surgical aggression. Conclusions: Improved use of electrodissection techniques, limiting and focusing the application of its energy, and preservation of peritonsillar mucosa are factors that may lower post-tonsillectomy pain levels (AU)


Subject(s)
Humans , Male , Female , Adult , Tonsillectomy , Pain, Postoperative/drug therapy , Electrocoagulation , Postoperative Hemorrhage , Intraoperative Complications , Electrosurgery/methods
6.
Acta Otorrinolaringol Esp ; 67(1): 23-32, 2016.
Article in English, Spanish | MEDLINE | ID: mdl-25888132

ABSTRACT

OBJECTIVE: Assessment of factors related to pharyngeal anatomy and surgical technique as possible causes of post-tonsillectomy pain. MATERIALS AND METHODS: This was a prospective observational study that included 42 patients undergoing tonsillectomy with cold and monopolar electric device dissection. We recorded duration of the entire operation, duration of electrocautery use, tonsil size and postoperative pain and discomfort assessed using a visual analogue scale (VS) and a 40-item questionnaire (QoR-40, Quality of Recovery), along with sequelae on returning to normal diet, weight loss and hospital stay. Correlations among quantitative variables were obtained by mean of lineal regression coefficients. RESULTS: Duration of surgery was 22.66 ± 7.07 minutes, removing tonsils with a volume of 6046.07 ± 3866.20 mm(3) and an electrocautery use time of 66.14 ± 37.77 seconds, applying 1984.24 ± 1133.32 joules per patient. The most frequently observed Mallampati classification and tonsil size scores were stages II and III. The VS score increased and QoR-40 decreased at 24 hours and 7 days, but differences were statistically non-significant. Joule amount used for electrocautery was the parameter that correlated the best with discomfort status as measured via assessment scores, analgesic and corticosteroid requirements, weight loss and hospital stay. Pain was higher in subjects submitted to peritonsillar surgical aggression. CONCLUSIONS: Improved use of electrodissection techniques, limiting and focusing the application of its energy, and preservation of peritonsillar mucosa are factors that may lower post-tonsillectomy pain levels.


Subject(s)
Pain, Postoperative , Tonsillectomy , Adult , Electrocoagulation/adverse effects , Humans , Pain Measurement , Pain, Postoperative/etiology , Palatine Tonsil , Prospective Studies , Tonsillectomy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...